NeoGenomics, Inc. (NEO) Operating income 2016–2025
NeoGenomics, Inc. (NEO) annual operating income history from SEC filings — each fiscal year as reported.
-$115.9MFY2025 · since FY2016: $2.2M → -$115.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$115.9M | -25.8% |
| FY2024 | -$92.1M | +14.5% |
| FY2023 | -$107.7M | +31.6% |
| FY2022 | -$157.6M | -32.7% |
| FY2021 | -$118.8M | -748.7% |
| FY2020 | -$14.0M | -207.6% |
| FY2019 | $13.0M | +29.5% |
| FY2018 | $10.0M | +246.0% |
| FY2017 | $2.9M | +34.7% |
| FY2016 | $2.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice